PureTech Historical Cash Flow

PRTC Stock

139.00 3.00 2.21%

Analysis of PureTech Health cash flow over time is an excellent tool to project PureTech Health plc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 94.2 M or Depreciation of 3.9 M as it is a great indicator of PureTech Health ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining PureTech Health plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PureTech Health plc is a good buy for the upcoming year.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About PureTech Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in PureTech balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which PureTech's non-liquid assets can be easily converted into cash.

PureTech Health Cash Flow Chart

At this time, PureTech Health's Other Cashflows From Investing Activities is comparatively stable compared to the past year. Investments is likely to gain to about 252.9 M in 2025, whereas Free Cash Flow is likely to drop (141.1 M) in 2025.

Stock Based Compensation Begin Period Cash Flow Dividends Paid Capital Expenditures

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by PureTech Health plc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of PureTech Health operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most accounts from PureTech Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into PureTech Health plc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2024	2025 (projected)
Capital Expenditures	2.2M	11K	10.5K
Dividends Paid	4.0M	4.6M	4.9M

Capital Expenditures Dividends Paid

PureTech Health cash flow statement Correlations

	Sale Purchase Of Stock	Change In Cash	Stock Based Compensation	Free Cash Flow	Change In Working Capital	Begin Period Cash Flow	Depreciation	Other Non Cash Items	Dividends Paid	Capital Expenditures	Change To Account Receivables	Net Income	End Period Cash Flow	Investments	Net Borrowings	Change To Operating Activities	Change To Netincome	Change To Liabilities	Issuance Of Capital Stock
Sale Purchase Of Stock		0.0	-0.38	0.46	0.24	-0.29	-0.36	0.56	-0.5	0.25	0.01	-0.16	-0.23	-0.64	0.02	0.47	0.21	0.09	0.53
Change In Cash	0.0		0.09	0.04	-0.59	-0.39	-0.12	0.29	0.26	0.11	0.47	0.07	0.44	0.65	0.58	0.01	-0.05	-0.04	-0.11
Stock Based Compensation	-0.38	0.09		-0.8	-0.27	0.56	0.56	-0.65	0.58	0.21	-0.22	0.23	0.56	0.45	-0.1	-0.53	-0.42	0.46	-0.63
Free Cash Flow	0.46	0.04	-0.8		0.04	-0.85	-0.92	0.62	-0.83	-0.25	0.23	-0.16	-0.77	-0.53	-0.05	0.76	0.49	-0.35	0.88
Change In Working Capital	0.24	-0.59	-0.27	0.04		0.15	0.2	0.19	-0.33	0.35	0.09	0.15	-0.3	-0.61	-0.33	0.21	-0.29	0.39	0.13
Begin Period Cash Flow	-0.29	-0.39	0.56	-0.85	0.15		0.85	-0.55	0.71	0.16	-0.39	-0.03	0.65	0.18	-0.16	-0.75	-0.25	0.25	-0.73
Depreciation	-0.36	-0.12	0.56	-0.92	0.2	0.85		-0.4	0.74	0.44	-0.24	0.31	0.72	0.42	0.13	-0.61	-0.62	0.32	-0.85
Other Non Cash Items	0.56	0.29	-0.65	0.62	0.19	-0.55	-0.4		-0.58	0.43	0.23	0.1	-0.24	-0.23	0.3	0.67	-0.01	0.14	0.62
Dividends Paid	-0.5	0.26	0.58	-0.83	-0.33	0.71	0.74	-0.58		-0.06	-0.01	-0.07	0.88	0.69	0.25	-0.88	-0.15	-0.06	-0.91
Capital Expenditures	0.25	0.11	0.21	-0.25	0.35	0.16	0.44	0.43	-0.06		-0.1	0.67	0.28	0.06	0.17	0.31	-0.77	0.63	-0.1
Change To Account Receivables	0.01	0.47	-0.22	0.23	0.09	-0.39	-0.24	0.23	-0.01	-0.1		-0.02	0.01	0.12	-0.07	-0.02	0.0	0.01	-0.03
Net Income	-0.16	0.07	0.23	-0.16	0.15	-0.03	0.31	0.1	-0.07	0.67	-0.02		0.02	0.24	-0.06	0.36	-0.87	0.27	-0.26
End Period Cash Flow	-0.23	0.44	0.56	-0.77	-0.3	0.65	0.72	-0.24	0.88	0.28	0.01	0.02		0.68	0.35	-0.69	-0.28	0.22	-0.77
Investments	-0.64	0.65	0.45	-0.53	-0.61	0.18	0.42	-0.23	0.69	0.06	0.12	0.24	0.68		0.45	-0.42	-0.34	-0.07	-0.63
Net Borrowings	0.02	0.58	-0.1	-0.05	-0.33	-0.16	0.13	0.3	0.25	0.17	-0.07	-0.06	0.35	0.45		-0.03	0.02	-0.23	-0.09
Change To Operating Activities	0.47	0.01	-0.53	0.76	0.21	-0.75	-0.61	0.67	-0.88	0.31	-0.02	0.36	-0.69	-0.42	-0.03		-0.08	0.01	0.78
Change To Netincome	0.21	-0.05	-0.42	0.49	-0.29	-0.25	-0.62	-0.01	-0.15	-0.77	0.0	-0.87	-0.28	-0.34	0.02	-0.08		-0.52	0.46
Change To Liabilities	0.09	-0.04	0.46	-0.35	0.39	0.25	0.32	0.14	-0.06	0.63	0.01	0.27	0.22	-0.07	-0.23	0.01	-0.52		-0.05
Issuance Of Capital Stock	0.53	-0.11	-0.63	0.88	0.13	-0.73	-0.85	0.62	-0.91	-0.1	-0.03	-0.26	-0.77	-0.63	-0.09	0.78	0.46	-0.05

Click cells to compare fundamentals

PureTech Health Account Relationship Matchups

PureTech Health cash flow statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Sale Purchase Of Stock	(12.9M)	(2.6M)	(26.5M)	(19.7M)	(107.6M)	(102.2M)
Change In Cash	271.5M	61.8M	(315.8M)	41.2M	89.6M	94.0M
Stock Based Compensation	10.7M	14.0M	14.7M	4.4M	22.9M	24.0M
Free Cash Flow	(137.3M)	(163.9M)	(181.0M)	(106.2M)	(134.4M)	(141.1M)
Change In Working Capital	(8.5M)	861K	15.9M	14.0M	(10.2M)	(9.7M)
Begin Period Cash Flow	132.4M	403.9M	465.7M	149.9M	191.1M	154.1M
Total Cashflows From Investing Activities	364.5M	197.4M	(107.2M)	69.0M	240.9M	252.9M
Other Cashflows From Financing Activities	38.7M	33.5M	358K	96.6M	89.7M	94.2M
Depreciation	6.6M	7.3M	8.9M	4.9M	3.6M	3.9M
Other Non Cash Items	6.1M	(5.1M)	(181.2M)	(62.6M)	(178.3M)	(169.4M)
Dividends Paid	1.1M	112K	6.0M	4.0M	4.6M	4.9M
Capital Expenditures	5.4M	5.7M	2.2M	245K	11K	10.5K
Total Cash From Operating Activities	(131.8M)	(158.3M)	(178.8M)	(105.9M)	(134.4M)	(127.7M)
Change To Account Receivables	(529K)	(617K)	(7.7M)	9.8M	629K	660.5K
Net Income	4.6M	(62.7M)	(37.1M)	(66.6M)	27.8M	29.2M
Total Cash From Financing Activities	38.9M	22.7M	(29.8M)	78.1M	(17.0M)	(16.1M)
End Period Cash Flow	403.9M	465.7M	149.9M	191.1M	280.6M	176.9M
Other Cashflows From Investing Activities	350K	(14.9M)	416K	690K	255K	267.8K
Investments	369.6M	197.4M	(107.2M)	69.0M	240.9M	252.9M
Net Borrowings	6.0M	(250K)	36.9M	(1.2M)	(1.3M)	(1.3M)
Change To Operating Activities	(438K)	2.9M	(3.4M)	(5.5M)	(4.9M)	(4.7M)
Change To Netincome	(41.9M)	(541.0M)	(135.9M)	(105.9M)	(95.3M)	(100.0M)
Issuance Of Capital Stock	2.0M	12.9M	332K	1.2M	895K	850.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

VALE	Vale SA ADR
EGY	Vaalco Energy
CMCSA	Comcast Corp

Additional Tools for PureTech Stock Analysis

When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC